Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 11, 2016
Source ID
10.1186/s12974-016-0620-9

Entities

People

  • Emiliano Trias
  • Ivan C. Moura
  • Joseph S. Beckman
  • Joël Babdor
  • Laura Martínez-palma
  • Laurent Gros
  • Luis Barbeito
  • Matthias Guillo
  • Olivier Hermine
  • Pablo Díaz-amarilla
  • Patrice Dubreuil
  • Patricia Cassina
  • Romina Barreto-núñez
  • Sofía Ibarburu
  • Thiago T. Maciel

Organizations

  • ALS Association
  • Agencia Nacional de Investigación e Innovación
  • National Institutes of Health
  • United States Department of Defense